Key stats
- Market cap
- 129B
- Open
- —
- Day range
- —
- 52-week range
- $45.27 – $68.64
- Volume
- 248K
- Avg volume
- 12.5M
Q3 FY26Beat
Expected$1.15
Actual$1.35
BMY
Bristol-Myers Squibb Company$62.98-$0.04-0.07%Price as of Nov 3, 2026, 9:34 AM ET
Earnings
Q2 FY26
Actual$1.62
Q1 FY26
Actual$1.31
Q4 FY25
Actual$0.53
About
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Employees
- 32,500
- Headquarters
- Princeton, NJ